Evaluating Autologous Platelet-Rich Fibrin Plasma for Chronic Lower Extremity Ulcers

StatusNot Yet Recruiting
PhasePhase 1/2
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
To prospectively evaluate the safety and efficacy of an Autologous Platelet-Rich Fibrin Plasma system when applied in conjunction with Standard of Care for management of chronic lower extremity wounds.
Trial Details
NCT Number NCT07862335
Lead Sponsor Tiger Biosciences, LLC.
Conditions
(from sponsor)		 Lower Extremity, Chronic Ulcers, Pressure Ulcer (PU), Venous Leg Ulcer (VLU), Wound Management
Related terms Pressure Ulcer, Varicose Ulcer
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov